Delcath Systems, Inc.
General ticker "DCTH" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $390.3M (TTM average)
Delcath Systems, Inc. follows the US Stock Market performance with the rate: 51.5%.
Estimated limits based on current volatility of 1.0%: low 16.27$, high 16.60$
Factors to consider:
- Total employees count: 96 (+26.3%) as of 2024
- Top business risk factors: Recurring operating losses, Commercialization failure, Regulatory and compliance, Cybersecurity threats, Sales channel retention
- Current price 53.2% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.09$, 10.82$]
- 2026-12-31 to 2027-12-31 estimated range: [4.43$, 9.50$]
Financial Metrics affecting the DCTH estimates:
- Positive: with PPE of 145.4 at the end of fiscal year the price was low
- Positive: -4.23 < Operating profit margin, % of 0.77
- Negative: negative Industry operating cash flow (median)
- Negative: Investing cash flow per share per price, % of -7.29 <= -4.49
- Positive: 1.88 < Return on assets ratio (scaled to [-100,100]) of 2.14
- Negative: Shareholder equity ratio, % of 89.96 > 63.63
Short-term DCTH quotes
Long-term DCTH plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.06MM | $37.20MM | $85.23MM |
| Operating Expenses | $40.25MM | $49.62MM | $84.57MM |
| Operating Income | $-38.18MM | $-12.41MM | $0.66MM |
| Non-Operating Income | $-9.50MM | $-13.98MM | $2.85MM |
| R&D Expense | $17.50MM | $13.87MM | $29.25MM |
| Income(Loss) | $-47.68MM | $-26.39MM | $3.51MM |
| Taxes | $0.00MM | $0.00MM | $0.81MM |
| Net Income(Loss)* | $-47.68MM | $-26.39MM | $2.70MM |
| Stockholders Equity | $15.78MM | $68.75MM | $111.22MM |
| Inventory | $3.32MM | $6.93MM | $10.25MM |
| Assets | $38.61MM | $76.59MM | $123.63MM |
| Operating Cash Flow | $-31.25MM | $-18.68MM | $22.52MM |
| Capital expenditure | $0.06MM | $0.56MM | $1.55MM |
| Investing Cash Flow | $-19.71MM | $-0.98MM | $-26.59MM |
| Financing Cash Flow | $51.78MM | $39.41MM | $15.05MM |
| Earnings Per Share** | $-2.94 | $-0.93 | $0.08 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.